The Molecular Landscape of Placental Dysfunction in Fetal Growth Restriction (FGR): From Integrated Signaling Networks to Epigenetic Control
Preprint
- 9 October 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Fetal growth restriction (FGR) is a major pregnancy complication linked to placental insufficiency, resulting from defective trophoblast differentiation, impaired maternal-fetal vascular adaptation, and altered nutrient sensing. This review synthesizes current evidence on the interconnected molecular networks driving placental dysfunction. We map the reciprocal crosstalk between the pro-inflammatory shift, highlighted by NLRP3 inflammasome-driven trophoblast pyroptosis, and dysregulated extracellular matrix remodeling mediated by the MMP-9/TIMP system. This hostile microenvironment feeds directly into the angiogenic imbalance defined by the sFlt-1/PlGF ratio, accelerating cellular senescence via p53 and disrupting survival hubs like the PTEN/PI3K/AKT axis. Consequently, downstream metabolic sensors, notably the mTOR pathway, are blunted, causing trafficking failure of essential amino acid (SNAT2, LAT1) and glucose (GLUT) transporters. Crucially, we introduce an original framework integrating emerging spatial transcriptomics and single-cell epigenomics, demonstrating that these pathomechanisms are anatomically regionalized rather than uniform. Finally, we provide a critical evaluation of translation-ready therapeutic targets, emphasizing that strict safety constraints against fetal teratogenesis render ligand-functionalized nanoparticles a non-negotiable prerequisite for placenta-selective drug delivery. Integrating molecular stratification with longitudinal biomarker profiling represents the next milestone for mechanism-based, targeted management of FGR.Keywords
All Related Versions
- Version 1, 2026-10-09, Preprints
- Published version: Biology, 15 (21), 2046.
This publication has 188 references indexed in Scilit:
- Placental hormones, IGF-1, and early-life growth: endocrine links between birth size and infant metabolic programming—a systematic reviewEuropean Journal of Pediatrics, 2026
- Placental Drug Delivery to Treat Pre‐Eclampsia and Fetal Growth RestrictionSmall, 2024
- Trophoblast-Targeted Liposomes for Placenta-Specific Drug Delivery2023
- Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restrictionUltrasound in Obstetrics & Gynecology, 2023
- FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restrictionInternational Journal of Gynecology & Obstetrics, 2021
- ISUOG Practice Guidelines: diagnosis and management of small‐for‐gestational‐age fetus and fetal growth restrictionUltrasound in Obstetrics & Gynecology, 2020
- AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsiaHistochemistry and Cell Biology, 2020
- Hypoxia and Placental DevelopmentBirth Defects Research, 2017
- Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblastApoptosis, 2010
- The Insulin-Like Growth Factor System in Adrenocortical Growth Control and Carcinogenesis2009